SCHEMBL25401435

SCHEMBL25401435

CC(=O)OCCc1ccc2nc(O)cnc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.39
PDE3A Q14432 3/20 0.39
P2RY12 Q9H244 3/20 0.39
APP P05067 4/20 0.38
YWHAG P61981 1/20 0.38
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
ALDH1A1 P00352 2/20 0.35
F2 P00734 1/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
AKR1B10 O60218 2/20 0.35
AKR1B1 P15121 2/20 0.35
HTT P42858 1/20 0.35
TNKS2 Q9H2K2 1/20 0.34
KDM4E B2RXH2 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAOB P27338 1/20 0.34
TYR P14679 1/20 0.33
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25399532 0.82 PDE3B (0.38) PDE3BPDE3AP2RY12APPMTNR1A
SCHEMBL25396335 0.76 SMN1; SMN2 (0.50) ALDH1A1F2KDM4ESMN1; SMN2MAOB
SCHEMBL20809627 0.74 TP53 (0.47) MTNR1AMTNR1BALDH1A1HTT
SCHEMBL25399578 0.74 GAA (0.53) ALDH1A1HPGDAKR1B1KDM4E
SCHEMBL31733937 0.73 ESR1 (0.47) ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL30306725 0.71 APP (0.68) APPYWHAGALDH1A1HPGDAKR1B1
SCHEMBL5613913 0.71 APP (0.68) APPYWHAGALDH1A1HPGDAKR1B1
SCHEMBL8031627 0.70 LDHA (0.50) ALDH1A1GLAKDM4ESMN1; SMN2
SCHEMBL18995952 0.70 MAP4K4 (0.43) ALDH1A1HPGDKDM4E
SCHEMBL15922937 0.69 NPC1 (0.60) ALDH1A1HPGDHTTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023169554-A1 METHIONINE ADENOSINE TRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2023-09-14 WO disclosed